Literature DB >> 22540246

Crystal structure of the native plasminogen reveals an activation-resistant compact conformation.

Y Xue1, C Bodin, K Olsson.   

Abstract

BACKGROUND: Plasminogen is the zymogen form of plasmin and the precursor of angiostatin. It has been implicated in a variety of disease states, including thrombosis, bleeding and cancers. The native plasminogen, known as Glu-plasminogen, contains seven domains comprising the N-terminal peptide domain (NTP), five kringle domains (K1-K5) and the C-terminal serine protease domain (SP). Previous studies have established that the lysine binding site (LBS) of the conserved kringle domains plays a crucial role in mediating the regulation of plasminogen function. However, details of the related conformational mechanism are unknown.
OBJECTIVES: We aim to understand in more detail the conformational mechanism of plasminogen activation involving the kringles.
METHODS: We crystallized the native plasminogen under physiologically relevant conditions and determined the structure at 3.5 Å resolution. We performed structural analyses and related these to the literature data to gain critical understanding of the plasminogen activation. RESULTS AND
CONCLUSIONS: The structure reveals the precise architecture of the quaternary complex. It shows that the Glu-plasminogen renders its compact form as an activation-resistant conformation for the proteolytic activation. The LBSs of all kringles, except K1, are engaged in intra-molecular interactions while only K1-LBS is readily available for ligand binding or receptor anchorage. The structure also provides insights into the interactions between plasminogen and α2-antiplasmin, the primary physiological inhibitor of plasmin. Furthermore, the data presented explain why a conformational transition to the open form is necessary for plasminogen activation as well as angiostatin generation, and provide a rationale for the functional hierarchy of the different kringles.
© 2012 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22540246     DOI: 10.1111/j.1538-7836.2012.04765.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  29 in total

1.  Identification and analyses of inhibitors targeting apolipoprotein(a) kringle domains KIV-7, KIV-10, and KV provide insight into kringle domain function.

Authors:  Jenny Sandmark; Anna Tigerström; Tomas Akerud; Magnus Althage; Thomas Antonsson; Stefan Blaho; Cristian Bodin; Jonas Boström; Yantao Chen; Anders Dahlén; Per-Olof Eriksson; Emma Evertsson; Tomas Fex; Ola Fjellström; David Gustafsson; Margareta Herslöf; Ryan Hicks; Emelie Jarkvist; Carina Johansson; Inge Kalies; Birgitta Karlsson Svalstedt; Fredrik Kartberg; Anne Legnehed; Sofia Martinsson; Andreas Moberg; Marianne Ridderström; Birgitta Rosengren; Alan Sabirsh; Anders Thelin; Johanna Vinblad; Annika U Wellner; Bingze Xu; Ann-Margret Östlund-Lindqvist; Wolfgang Knecht
Journal:  J Biol Chem       Date:  2020-03-04       Impact factor: 5.157

2.  A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation.

Authors:  Zonne L M Hofman; Chantal C Clark; Wariya Sanrattana; Aziz Nosairi; Naomi M J Parr; Minka Živkovic; Karoline Krause; Niklas A Mahnke; Jörg Scheffel; C Erik Hack; Marcus Maurer; Steven de Maat; Coen Maas
Journal:  J Biol Chem       Date:  2019-11-26       Impact factor: 5.157

3.  Disorder and cysteines in proteins: A design for orchestration of conformational see-saw and modulatory functions.

Authors:  Anukool A Bhopatkar; Vladimir N Uversky; Vijayaraghavan Rangachari
Journal:  Prog Mol Biol Transl Sci       Date:  2020-06-27       Impact factor: 3.622

Review 4.  Pathogen activators of plasminogen.

Authors:  I M Verhamme; P R Panizzi; P E Bock
Journal:  J Thromb Haemost       Date:  2015-06       Impact factor: 5.824

5.  Deciphering Key Residues Involved in the Virulence-promoting Interactions between Streptococcus pneumoniae and Human Plasminogen.

Authors:  Christophe Moreau; Rémi Terrasse; Nicole M Thielens; Thierry Vernet; Christine Gaboriaud; Anne Marie Di Guilmi
Journal:  J Biol Chem       Date:  2016-12-23       Impact factor: 5.157

6.  Discovery of the Fibrinolysis Inhibitor AZD6564, Acting via Interference of a Protein-Protein Interaction.

Authors:  Leifeng Cheng; Daniel Pettersen; Bengt Ohlsson; Peter Schell; Michael Karle; Emma Evertsson; Sara Pahlén; Maria Jonforsen; Alleyn T Plowright; Jonas Boström; Tomas Fex; Anders Thelin; Constanze Hilgendorf; Yafeng Xue; Göran Wahlund; Walter Lindberg; Lars-Olof Larsson; David Gustafsson
Journal:  ACS Med Chem Lett       Date:  2014-02-18       Impact factor: 4.345

Review 7.  New insights into the role of Plg-RKT in macrophage recruitment.

Authors:  Lindsey A Miles; Shahrzad Lighvani; Nagyung Baik; Caitlin M Parmer; Sophia Khaldoyanidi; Barbara M Mueller; Robert J Parmer
Journal:  Int Rev Cell Mol Biol       Date:  2014       Impact factor: 6.813

8.  Molecular pathogenesis of plasminogen Hakodate: the second Japanese family case of severe type I plasminogen deficiency manifested late-onset multi-organic chronic pseudomembranous mucositis.

Authors:  Tsukasa Osaki; Masayoshi Souri; Young-Seok Song; Naohiro Izumi; Ruby Law; Akitada Ichinose
Journal:  J Thromb Thrombolysis       Date:  2016-08       Impact factor: 2.300

Review 9.  Plasminogen receptors: the first quarter century.

Authors:  Lindsey A Miles; Robert J Parmer
Journal:  Semin Thromb Hemost       Date:  2013-03-26       Impact factor: 4.180

10.  Crystal Structure of the Michaelis Complex between Tissue-type Plasminogen Activator and Plasminogen Activators Inhibitor-1.

Authors:  Lihu Gong; Min Liu; Tu Zeng; Xiaoli Shi; Cai Yuan; Peter A Andreasen; Mingdong Huang
Journal:  J Biol Chem       Date:  2015-08-31       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.